relapsed refractory

Related by string. Relapsed Refractory * Relapsed . Relapsing : relapsed refractory multiple myeloma . relapsing remitting multiple sclerosis / Refractory : hormone refractory prostate cancer * relapsed refractory AML . relapsed refractory aggressive . Relapsed Refractory Multiple Myeloma . relapsed refractory ALL . relapsed refractory pediatric . Relapsed Refractory Aggressive *

Related by context. Frequent words. (Click for all words.) 69 chronic lymphocytic leukemia CLL 66 chronic myeloid leukemia CML 66 resistant ovarian cancer 65 rituximab 65 fludarabine 65 B CLL 65 Marqibo 65 hematologic malignancies 65 Rituximab 64 IMGN# 64 antitumor activity 63 cutaneous T cell 63 temozolomide 63 cell malignancies 63 lupus nephritis 63 blinatumomab 63 follicular lymphoma 63 refractory 63 relapsed 63 chemotherapy regimens 62 unresectable 62 HRPC 62 myelofibrosis 62 dasatinib 62 sunitinib 62 monotherapy 62 vandetanib 62 Pixantrone 62 NSCLC 62 evaluable patients 61 relapsing remitting multiple sclerosis 61 ofatumumab 61 TREANDA 61 ZEVALIN 61 CTCL 61 humanized monoclonal antibody 61 CLL 61 cytarabine 61 bortezomib 61 imatinib 61 metastatic colorectal cancer 61 solid tumors 60 cell lymphomas 60 Perifosine 60 REVLIMID 60 mitoxantrone 60 Phase Ib 59 HGS ETR1 59 autologous stem cell 59 advanced NSCLC 59 sorafenib 59 chemoradiation 59 evaluable 59 AP# [003] 59 hormone refractory prostate cancer 59 soft tissue sarcomas 59 cetuximab 59 myelodysplastic syndromes 59 docetaxel 59 renal cell carcinoma 59 Torisel 59 Taxotere R 59 INCB# [002] 59 carfilzomib 59 bone metastases 59 hematologic 59 epratuzumab 58 cytotoxic 58 cyclophosphamide 58 topotecan 58 fluorouracil 58 G CSF 58 5 FU 58 erlotinib 58 VELCADE 58 perifosine 58 gefitinib 58 myelodysplastic syndromes MDS 58 multiple myeloma 58 Phase 1b 58 chemotherapeutic agent 58 hepatocellular carcinoma HCC 58 MGCD# [001] 58 carboplatin 58 mCRC 58 investigational compound 58 DMARDs 58 rheumatoid arthritis RA 58 gemcitabine 58 trastuzumab 58 dose escalation 58 randomized Phase 58 Phase IIa trial 58 Phase 2a trial 58 acute myeloid leukemia AML 58 hematologic cancers 57 pemetrexed 57 immunosuppressant 57 adalimumab 57 kinase inhibitor 57 free survival PFS

Back to home page